Burling Wealth Partners’s Merck MRK Stock Holding History
Bought
Maintained
Sold
Other funds holding MRK
Burling Wealth Partners's MRK Position: Q2 2026 in Review
Burling Wealth Partners reduced its Merck (MRK) stake by 2.7% in Q2 2026, selling an estimated $84.2K and leaving 26,244 shares worth $3.37M. The position accounts for 0.49% of the portfolio, ranked #52.
Burling Wealth Partners first reported a position in MRK in Q4 2024 and has held it in 7 quarters since. The position peaked at $5.61M in Q4 2024. 3,834 funds tracked by Wall St. Rank hold MRK as of Q2 2026.
- Burling Wealth Partners held 26,244 shares of Merck worth $3.37M as of Q2 2026.
- Burling Wealth Partners sold 719 Merck shares in Q2 2026, an estimated $84.2K.
- Merck made up 0.49% of Burling Wealth Partners's portfolio in Q2 2026, its #52 holding.
- Burling Wealth Partners first reported a position in Merck in Q4 2024 and has held it in 7 quarters since.
- Burling Wealth Partners's Merck position peaked at $5.61M in Q4 2024.
- 3,834 funds tracked by Wall St. Rank held Merck as of Q2 2026.
Based on Burling Wealth Partners's 13F filing for Q2 2026, filed 4 Aug 2026.